Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AtaiBeckley Inc. - Common Stock
(NQ:
ATAI
)
4.970
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AtaiBeckley Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
30
31
Next >
Psychedelic Stock Gainers And Losers From March 28, 2023
↗
March 28, 2023
Via
Benzinga
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
↗
March 27, 2023
Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 27, 2023
↗
March 27, 2023
Via
Benzinga
Expert Ratings for ATAI Life Sciences
↗
March 27, 2023
Via
Benzinga
ATAI Life Sciences Earnings Perspective: Return On Capital Employed
↗
March 27, 2023
Via
Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
↗
March 24, 2023
Via
Benzinga
The Latest Analyst Ratings for ATAI Life Sciences
↗
March 07, 2023
Via
Benzinga
Atai Life Sciences Hopes Hercules Can Help 'Sustain' Operations Until 2026
↗
March 24, 2023
Biopharma company Atai Life Sciences' (NASDAQ: ATAI) fourth quarter and full year 2022 consolidated financial results show:
Via
Benzinga
atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights
March 24, 2023
From
atai Life Sciences
Via
GlobeNewswire
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
↗
March 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 22, 2023
↗
March 22, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 21, 2023
↗
March 21, 2023
Via
Benzinga
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion
↗
March 21, 2023
This is the third article of a three-part series, you can find the first and
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 20, 2023
↗
March 20, 2023
Via
Benzinga
An Update On The Performance Of The 7 Largest Psychedelic Stocks
↗
March 19, 2023
The 7 largest psychedelic drug stocks are ranked as to their stock performances since the beginning of March and year-to-date, their likelihood of financial distress, analyst price forecasts and the...
Via
Talk Markets
The "Rags-To-Riches" Portfolio: An Update
↗
March 18, 2023
Cannabis, psychedelic, and plant-based food stocks performed extremely poorly in 2022, down 73% vs. 2021 but perhaps some of them will bounce back with major returns in 2023.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From March 17, 2023
↗
March 17, 2023
Via
Benzinga
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
↗
March 16, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
↗
March 15, 2023
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
↗
March 14, 2023
Via
Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
↗
March 13, 2023
Via
Benzinga
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
↗
March 13, 2023
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
March 14, 2023
Tuesday's morning session saw 84 companies set new 52-week lows.
Via
Benzinga
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
↗
March 13, 2023
The Benzinga Psychedelics Capital Conference (PCC) is rapidly becoming the place to be for all those interested or involved in the space. In addition to being the place where deals are done, you'll...
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
↗
March 10, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
↗
March 09, 2023
Via
Benzinga
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
March 08, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
March 07, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
↗
March 06, 2023
Via
Benzinga
Atai Update: Ketamine Trials Are Ongoing, Company Cuts 30% Workforce
↗
March 06, 2023
The clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) founded in 2018 shared updates on the two clinical trials as well as its plan to streamline its workforce with significant...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
